Georgia Capital PLC (LON:CGEO)

London · Delayed Price · Currency is GBP · Price in GBX

3,875.00

-20.00 (-0.51%)

May 8, 2026, 4:47 PM GMT

116.00% (1Y)

Market Cap	1.16B +120.6%
Revenue (ttm)	541.27M +430.0%
Net Income	445.54M +288.5%
EPS	n/a
Shares Out	30.02M
PE Ratio	2.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,177
Average Volume	66,104
Open	3,845.00
Previous Close	3,895.00
Day's Range	3,840.00 - 3,925.00
52-Week Range	1,768.00 - 4,190.00
Beta	0.64
RSI	48.16
Earnings Date	Apr 28, 2026

About Georgia Capital

Georgia Capital PLC is a private equity and venture capital firm specializing in early stage, organic growth and acquisitions. It considers Greenfields through mature stage companies. The firm typically invests in automotive retail, education services, hotels, resorts & cruise lines, restaurants, beverages, healthcare, banks, property and casualty insurance, life and health insurance, diversified REITs, water utilities, and renewable electricity. It seeks to invest in Georgia. The firm seeks board position in public portfolio companies. It exit... [Read more]

Industry Financial Conglomerates

Sector Financials

Founded 2017

Employees 20,259

Stock Exchange London Stock Exchange

Ticker Symbol CGEO

Full Company Profile

Financial Performance

In 2025, Georgia Capital's revenue was 1.90 billion, an increase of 415.81% compared to the previous year's 368.10 million. Earnings were 1.89 billion, an increase of 422.43%.

Financial numbers in GEL Financial Statements

News

Georgia Capital Earnings Call Transcript: Q1 2026

NAV per share grew over 9% year-to-date, driven by strong portfolio company performance and buybacks. Retail Pharmacy, Healthcare, and Insurance segments all posted double-digit revenue and EBITDA growth, while capital return and expansion in Armenia remain strategic priorities.

11 days ago - Transcripts

Georgia Capital Earnings Call Transcript: H2 2025

EV per share rose 14.1% in Q4 and 61% for the year, driven by strong portfolio and macroeconomic performance. Capital return program is ahead of schedule, with 80% completed, and key segments—retail pharmacy, insurance, and healthcare—delivered double-digit growth and robust cash flow.

2 months ago - Transcripts

Georgia Capital Earnings Call Transcript: Q3 2025

NAV per share rose nearly 8% in Q3, driven by strong operating results and share buybacks. Retail pharmacy, insurance, and healthcare segments all posted double-digit growth, with record profitability and robust cash flow. Capital return and dividend programs are ahead of schedule.

6 months ago - Transcripts

Georgia Capital Earnings Call Transcript: H1 2025

NAV per share rose 17.7% in Q2, driven by strong revenue and EBITDA growth across all major segments. GEL 300 million buyback completed early; new GEL 700 million capital return program launched. Insurance achieved investment-grade rating, and all segments reported robust cash generation.

9 months ago - Transcripts

Georgia Capital Earnings Call Transcript: Q1 2025

NAV per share rose 11.2% in Q1, driven by strong revenue and EBITDA growth in private portfolio companies. Aggressive buybacks continued, with over 27% of shares repurchased, and dividend income per share increased 11.6%. Georgia's macro environment remains robust, supporting further growth.

1 year ago - Transcripts